Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
4527 On Other Exchanges
4527 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

rohto pharmaceutical co ltd (4527) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ROHTO PHARMACEUTICAL CO LTD (4527)

Related News

No related news articles were found.

rohto pharmaceutical co ltd (4527) Related Businessweek News

No Related Businessweek News Found

rohto pharmaceutical co ltd (4527) Details

ROHTO Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods in Japan and internationally. It offers eye care products, including eye drops and contact lens care products; oral medicines, such as gastrointestinal medicines, Chinese herbal medicines, and supplements; and skin care products, as well as eye wash products and regenerative medicines. The company also operates beauty counters that provide skin care products under the episteme and Obagi brand names, as well as offers beauty treatments. In addition, it operates a restaurant, an urban vegetable farm, and a relaxation salon. The company was formerly known as Yamada Pharmaceutical and changed its name to ROHTO Pharmaceutical Co., Ltd. in 1949. ROHTO Pharmaceutical Co., Ltd. was founded in 1899 and is headquartered in Osaka, Japan.

6,426 Employees
Last Reported Date: 06/24/15
Founded in 1899

rohto pharmaceutical co ltd (4527) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: ¥160.0M
Compensation as of Fiscal Year 2015.

rohto pharmaceutical co ltd (4527) Key Developments

Rohto Pharmaceutical Co., Ltd., Q2 2016 Earnings Call, Nov 13, 2015

Rohto Pharmaceutical Co., Ltd., Q2 2016 Earnings Call, Nov 13, 2015

International Stem Cell Corp. Updates on Next Phase of Research Collaboration with Rohto Pharmaceutical

International Stem Cell Corp. reported that it has entered into the second phase of the existing Research Agreement with Rohto Pharmaceutical Co. After successfully completing preliminary studies of ISCO's human parthenogenetic neural stem cells (hpNSCs) Rohto acknowledged that ISCO's proprietary cells demonstrate consistent high quality and are suitable for further use in Rohto's research. If Rohto successfully demonstrates hpNSCs' efficacy in rodent models, which could lead to a possible treatment of a variety of degenerative eye disorders, Rohto will enter into negotiations of a definitive license agreement with ISCO in order to license ISCO's proprietary technology for therapeutic and commercial use.

Rohto Pharmaceutical Co., Ltd. Presents at 2015 Mizuho Investment Conference, Sep-07-2015

Rohto Pharmaceutical Co., Ltd. Presents at 2015 Mizuho Investment Conference, Sep-07-2015 . Venue: Palace Hotel, Tokyo, Japan.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4527:JP ¥2,417.00 JPY +14.00

4527 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4527.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4527 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ROHTO PHARMACEUTICAL CO LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at